by newsworm | Mar 8, 2025 | Apollo Hospital, Pharma
Here is a summary of the content in 400 words: On Saturday, the Hyderabad Metro Rail successfully created a dedicated green channel for transporting a live heart from Kamineni Hospitals in LB Nagar to Apollo Hospitals in Jubilee Hills. This milestone was achieved... by newsworm | Mar 8, 2025 | Fortis, Pharma
On International Women’s Day, Delhi Chief Minister Rekha Gupta emphasized the importance of strengthening the city’s healthcare system and prioritizing women’s education as crucial for building a progressive and inclusive society. She reiterated the... by newsworm | Mar 8, 2025 | Pharma
Here is a summary of the content in 400 words: The Telangana Cabinet, led by Chief Minister A. Revanth Reddy, has approved the development of a 30,000-acre “Future City” between Srisailam and Nagarjunasagar highways. This city is designed to be... by newsworm | Mar 8, 2025 | Lupin, Pharma
Lupin, a global pharmaceutical company, has launched its anti-clotting drug Rivaroxaban in the US market. The company has received approval from the United States Food and Drug Administration (FDA) to market the medication, which is used to treat conditions such as... by newsworm | Mar 8, 2025 | Pharma
Here is a summary of the content in 400 words: ILUMYA, a novel biologic treatment, has been found effective in treating moderate-to-severe plaque psoriasis affecting the nails in a recent study presented at the 2025 American Academy of Dermatology (AAD) conference.... by newsworm | Mar 7, 2025 | Biocon, Pharma
Biocon Biologics has announced positive results from the Phase 3 clinical trial for its biosimilar, Yesintek, in treatment-naive patients with moderate-to-severe plaque psoriasis. The study met its primary endpoint, demonstrating the efficacy and safety of Yesintek in...